BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1418 related articles for article (PubMed ID: 28919734)

  • 1. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.
    Andrianopoulos V; Franssen FM; Peeters JP; Ubachs TJ; Bukari H; Groenen M; Burtin C; Vogiatzis I; Wouters EF; Spruit MA
    Respir Physiol Neurobiol; 2014 Jan; 190():40-6. PubMed ID: 24121092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia.
    Nakahara Y; Taniguchi H; Kimura T; Kondoh Y; Arizono S; Nishimura K; Sakamoto K; Ito S; Ando M; Hasegawa Y
    Respirology; 2017 Jan; 22(1):120-125. PubMed ID: 27471142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
    Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
    Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.
    Perez T; Deslée G; Burgel PR; Caillaud D; Le Rouzic O; Zysman M; Escamilla R; Jebrak G; Chanez P; Court-Fortune I; Brinchault-Rabin G; Nesme-Meyer P; Paillasseur JL; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1399-1410. PubMed ID: 31308646
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.
    Andrianopoulos V; Celli BR; Franssen FM; Pinto-Plata VM; Calverley PM; Vanfleteren LE; Vogiatzis I; Vestbo J; Agusti A; Bakke PS; Rennard SI; MacNee W; Tal-Singer R; Yates JC; Wouters EF; Spruit MA
    Respir Med; 2016 Oct; 119():87-95. PubMed ID: 27692154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD.
    Díaz AA; Pinto-Plata V; Hernández C; Peña J; Ramos C; Díaz JC; Klaassen J; Patino CM; Saldías F; Díaz O
    Respir Med; 2015 Jul; 109(7):882-9. PubMed ID: 25952774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between steps of 6MWT and COPD severity: a cross-sectional study.
    Zeng GS; Chen LC; Fan HZ; Wu LL; Wu XP; Fang ZK; He X; Yu HP
    Int J Chron Obstruct Pulmon Dis; 2019; 14():141-148. PubMed ID: 30643400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-defined emphysema in COPD patients and risk for change in desaturation status in 6-min walk test.
    Waatevik M; Frisk B; Real FG; Hardie JA; Bakke P; Eagan TM; Johannessen A
    Respir Med; 2021 Oct; 187():106542. PubMed ID: 34340175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document.
    Suzuki T; Tada Y; Kawata N; Ikari J; Kasahara Y; Sakurai Y; Iesato K; Nishimura R; West J; Tatsumi K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1199-205. PubMed ID: 26150711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-minute walk work for assessment of functional capacity in patients with COPD.
    Carter R; Holiday DB; Nwasuruba C; Stocks J; Grothues C; Tiep B
    Chest; 2003 May; 123(5):1408-15. PubMed ID: 12740255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease.
    Sugiyama Y; Asai K; Yamada K; Kureya Y; Ijiri N; Watanabe T; Kanazawa H; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():765-772. PubMed ID: 28424548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.
    Balasubramanian A; Putcha N; MacIntyre NR; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Regan E; Make BJ; Hansel NN; Wise RA; McCormack MC
    Ann Am Thorac Soc; 2023 Jan; 20(1):38-46. PubMed ID: 35969416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 71.